| MODERNA INC. DL-,0001 |
| USA |
| Gesundheit |
| US60770K1079 / A2N9D9 |
| 0QF (Frankfurt) / MRNA (NASDAQ) |
| FRA:0QF, ETR:0QF, 0QF:GR, NASDAQ:MRNA |
| S&P500 |
| https://www.modernatx.com.. |
|
Moderna, Inc. is a biotechnology company specializing in the development of transformative medicines using messenger ribonucleic acid (mRNA) technology. Its primary focus lies in creating innovative therapeutics across multiple modalities, including ..
>Volltext.. |
| 19941.83 Mio. EUR |
| 16560.21 Mio. EUR |
| 1930.68 Mio. EUR |
| -2756.75 Mio. EUR |
| -2771.5 Mio. EUR |
| -7.07 EUR |
| 1126.3 Mio. EUR |
| 1655.61 Mio. EUR |
| -1272.08 Mio. EUR |
| 2.17 |
| -34.42% |
| 10.91% |
| - |
| - |
| - |
| MODERNA |
| 04.08.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|